DLB
Dolby Laboratories
57.60$
-0.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 49.7% | 49.4% | 51.0% | 49.4% | 38.2% | 40.7% | 43.0% | 41.9% | 43.0% | 44.1% | 43.5% | 42.0% | |
| 27.3% | 24.1% | 27.1% | 26.0% | 18.5% | 19.4% | 23.2% | 21.9% | 21.7% | 20.2% | 18.3% | 21.2% | |
| 32.0% | 28.9% | 30.9% | 30.5% | 18.5% | 19.4% | 23.2% | 21.9% | 21.8% | 20.2% | 18.3% | 21.2% | |
| 14.8% | 17.4% | 17.3% | 16.0% | 16.4% | 17.7% | 16.9% | 15.7% | 15.9% | 17.9% | 19.4% | 15.6% | |
| 1.2% | 1.3% | 1.2% | 1.2% | 1.1% | 1.0% | 1.1% | 1.0% | 0.9% | 1.0% | 1.0% | 1.0% | |
| 17.4% | – | – | – | 16.6% | 16.2% | 15.7% | 16.0% | 15.6% | 15.7% | – | – | |
| 13.6% | 14.0% | 13.4% | 13.7% | 17.0% | 16.5% | 16.3% | 16.5% | 16.4% | 16.6% | 16.3% | 16.7% | |
| 5.6% | 5.4% | 5.0% | 4.9% | 13.9% | 13.3% | 12.8% | 12.8% | 12.3% | 11.4% | 12.0% | 12.1% | |
| 20.8% | 19.5% | 19.9% | 17.7% | 20.6% | 20.3% | 20.0% | 18.2% | 18.5% | 18.5% | 19.2% | 17.9% | |
| 14.1% | 13.4% | 14.5% | 11.9% | 13.3% | 14.0% | 14.2% | 12.2% | 13.6% | 13.9% | 14.6% | 13.2% | |
| 0.5% | 0.4% | 0.5% | 0.4% | 0.4% | 0.4% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | |
| 0.7% | 0.5% | 0.6% | 0.6% | 0.6% | 0.4% | 0.5% | 0.5% | 0.6% | 0.3% | 0.6% | 0.4% | |
| 78.6% | 79.9% | 79.5% | 81.8% | 79.1% | 79.4% | 79.7% | 81.5% | 81.3% | 81.3% | 80.6% | 81.8% | |
| 79.9% | 80.6% | 80.5% | 82.8% | 79.7% | 80.5% | 80.6% | 81.9% | 81.6% | 81.6% | 80.9% | 82.3% | |
| 3.3% | 3.3% | 3.2% | 3.3% | 3.1% | 3.1% | 3.0% | 3.0% | 3.0% | 3.0% | 2.9% | 3.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.